AHR and irritable bowel syndrome: Decreased tryptophan metabolic levels are associated with impaired intestinal epithelial barriers in IBD, and some gut microbes could convert tryptophan into bioactive molecules, activate aromatic hydrocarbon receptors, and lower inflammation [5].